Stay updated on Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer revision label was updated from “v3.5.2” to “v3.5.3,” indicating a site/version release without changing the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:46.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed. This appears to be a site version update with no visible changes to study content.
    Difference
    0.1%
    Check dated 2026-03-19T05:24:38.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a behind-the-scenes maintenance update with no changes to study information or navigation.
    Difference
    0.1%
    Check dated 2026-03-12T02:15:38.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied with update dates (2026-02-05, 2026-02-03, 2026-02). A funding-lapse notice was removed from the page.
    Difference
    0.6%
    Check dated 2026-02-11T12:08:09.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a general notice about government funding lapse and NIH Clinical Center status, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:23.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.